Insulin Aspart

@article{Simpson2012InsulinA,
  title={Insulin Aspart},
  author={K. Simpson and C. Spencer},
  journal={Drugs},
  year={2012},
  volume={57},
  pages={759-765}
}
Abstract▴ Insulin aspart is a recombinant analogue of human insulin. Following subcutaneous insulin injection (0.15 to 0.2 U/kg), significantly higher serum insulin concentrations are achieved in a shorter time with insulin aspart than with human insulin. The subsequent decline in serum insulin concentrations is also more rapid with insulin aspart.▴ In healthy individuals undergoing euglycaemic glucose clamp testing, glucose infusion rates were higher and reached maximum concentrations… Expand
8 Citations
Insulin Analogs and Cancer
  • 33
Insulin and its analogs: actions via insulin and IGF receptors
  • 59
Insulin Aspart
Insulin analogues
  • PDF
Implantable batteryless device for on-demand and pulsatile insulin administration
  • 19
  • PDF

References

SHOWING 1-10 OF 18 REFERENCES
Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
  • 148
  • Highly Influential
Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28Asp
  • 92
  • Highly Influential
Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp).
  • 18
  • Highly Influential
Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.
  • 22
...
1
2
...